Related references
Note: Only part of the references are listed.Fecal Markers: Calprotectin and Lactoferrin
Bincy P. Abraham et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2012)
Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome
H. M. Staudacher et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2011)
Impact of the synbiotic combination of Lactobacillus casei shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in healthy subjects
Vicky De Preter et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Solid-Phase Microextraction and the Human Fecal VOC Metabolome
Emma Dixon et al.
PLOS ONE (2011)
Validation of Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome: A Critical Review
William E. Whitehead et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
Savio C. Reddymasu et al.
BMC GASTROENTEROLOGY (2010)
A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome
Caroline Codling et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
Valle Garcia-Sanchez et al.
JOURNAL OF CROHNS & COLITIS (2010)
Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease
J. P. Gisbert et al.
DIGESTIVE AND LIVER DISEASE (2009)
Analysis of Faecal Volatile Organic Compounds in Preterm Infants Who Develop Necrotising Enterocolitis: A Pilot Study
Catherine E. Garner et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)
A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis
C. E. Garner et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2009)
Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome
Kajsa Kajander et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
Charlotte M. T. Otten et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2008)
Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry
Ruyi Xue et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
An analysis of volatiles in the headspace of the faeces of neonates
B. De Lacy Costello et al.
JOURNAL OF BREATH RESEARCH (2008)
Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae
M. Elia et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
Catherine E. Garner et al.
FASEB JOURNAL (2007)
Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence
Faiz Ali et al.
GUT (2007)
Mechanisms of hypersensitivity in IBS and functional disorders
F. Azpiroz et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Metabolic profiling technologies for biomarker discovery in biomedicine and drug development
Goetz Schlotterbeck et al.
PHARMACOGENOMICS (2006)
Irritable bowel syndrome: The burden and unmet needs in Europe
E. M. M. Quigley et al.
DIGESTIVE AND LIVER DISEASE (2006)
Metabolomic approaches to phenotype characterization and applications to complex diseases
Matej Oresic et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2006)
Fundamentals of neurogastroenterology:: Basic science
David Grundy et al.
GASTROENTEROLOGY (2006)
Costs of irritable bowel syndrome in the UK and US
S Maxion-Bergemann et al.
PHARMACOECONOMICS (2006)
Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease
Michael R. Konikoff et al.
INFLAMMATORY BOWEL DISEASES (2006)
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
F Costa et al.
GUT (2005)
A novel method for rapidly diagnosing the causes of diarrhoea
CSJ Probert et al.
GUT (2004)
Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers
S Gonlachanvit et al.
GUT (2004)
Review article: epidemiology and quality of life in functional gastrointestinal disorders
L Chang
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Detection of lung cancer with volatile markers in the breath
M Phillips et al.
CHEST (2003)
Methane production during lactulose breath test is associated with gastrointestinal disease presentation
M Pimentel et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
JA Tibble et al.
GASTROENTEROLOGY (2002)
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome
J Jones et al.
GUT (2000)
Share Paper
